PDE8A Antikörper (N-Term)
(3 Referenzen)-
- Target Alle PDE8A Antikörper anzeigen
- PDE8A (phosphodiesterase 8A (PDE8A))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Maus, Ratte, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PDE8A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (IF), Immunocytochemistry (ICC), Confocal Microscopy (CM)
- Aufreinigung
- Affinity Purified
- Immunogen
- Synthetic peptide common to all PDE8A variants.
- Isotyp
- IgG
- Top Product
- Discover our top product PDE8A Primärantikörper
-
anti-phosphodiesterase 8A (PDE8A) (AA 32-121) antibody
PDE8A Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1H6 unconjugated
anti-phosphodiesterase 8A (PDE8A) (Leu572) antibodyPDE8A Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 8A (PDE8A) (AA 596-829) antibodyPDE8A Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 8A (PDE8A) antibodyPDE8A Reaktivität: Human WB Wirt: Maus Monoclonal EM-52 unconjugated
anti-phosphodiesterase 8A (PDE8A) (AA 681-730) antibodyPDE8A Reaktivität: Human, Maus, Ratte, Affe, Kaninchen, Rind (Kuh), Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 8A (PDE8A) (AA 551-600) antibodyPDE8A Reaktivität: Human, Ratte, Affe, Kaninchen, Hund, Pferd, Rind (Kuh), Meerschweinchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 8A (PDE8A) antibodyPDE8A Reaktivität: Human IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 8A (PDE8A) (AA 1-829) antibodyPDE8A Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-phosphodiesterase 8A (PDE8A) (AA 1-120) antibodyPDE8A Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 8A (PDE8A) antibodyPDE8A Reaktivität: Human, Maus, Kaninchen, Hund, Pferd, Schwein, Gorilla IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.65 μg/μL
-
-
: "Cyclic nucleotide phosphodiesterases in human spermatozoa and seminal fluid: Presence of an active PDE10A in human spermatozoa." in: Biochimica et biophysica acta, Vol. 1861, Issue 2, pp. 147-156, (2017) (PubMed).
: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).
: "Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac." in: The Biochemical journal, Vol. 456, Issue 3, pp. 463-73, (2013) (PubMed).
-
: "Cyclic nucleotide phosphodiesterases in human spermatozoa and seminal fluid: Presence of an active PDE10A in human spermatozoa." in: Biochimica et biophysica acta, Vol. 1861, Issue 2, pp. 147-156, (2017) (PubMed).
-
- Target
- PDE8A (phosphodiesterase 8A (PDE8A))
- Andere Bezeichnung
- PDE8A (PDE8A Produkte)
- Synonyme
- PDE8A antikoerper, Pde8a antikoerper, HsT19550 antikoerper, AI551852 antikoerper, Pde8 antikoerper, RNPDE8A antikoerper, phosphodiesterase 8A antikoerper, PDE8A antikoerper, Pde8a antikoerper, pde8a antikoerper
- NCBI Accession
- NM_008803
- UniProt
- Q86XV4
- Pathways
- cAMP Metabolic Process
-
